Pet therapies
The therapies are being created to treat metabolic conditions and digestive disorders in pets.
Source: LinkedIn company description · Retrieved October 13, 2026
Bactana is a development-stage animal health company formed in collaboration with Cornell University.
The company has patented the use of selected microbes to manipulate animals’ microbial ecology and affect interactions among the microbiome, immune system, and metabolism. Bactana is creating pet therapies and developing products for livestock production.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The therapies are being created to treat metabolic conditions and digestive disorders in pets.
Source: LinkedIn company description · Retrieved October 13, 2026
The products are being developed for livestock production to reduce natural resource utilization, greenhouse gas emissions, and antibiotic usage.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.